Hosted on MSN

Global study finds heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients

A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with ...
Monthly Prescribing Reference

Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis

No reduction seen in the composite outcome of cardiovascular mortality, hospitalization due to heart failure. HealthDay News — Spironolactone does not reduce a composite outcome of cardiovascular ...